Mapping genes for drug chronotherapy
• Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficaciou...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Wei, Kun [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Triazolopyridazine LRRK2 kinase inhibitors - 2013, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:23 ; year:2018 ; number:11 ; pages:1883-1888 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.drudis.2018.06.011 |
|---|
| Katalog-ID: |
ELV044655673 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV044655673 | ||
| 003 | DE-627 | ||
| 005 | 20230624111913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181113s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.drudis.2018.06.011 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000417.pica |
| 035 | |a (DE-627)ELV044655673 | ||
| 035 | |a (ELSEVIER)S1359-6446(18)30023-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 630 |q VZ |
| 084 | |a 22 |2 ssgn | ||
| 084 | |a 46.00 |2 bkl | ||
| 100 | 1 | |a Wei, Kun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mapping genes for drug chronotherapy |
| 264 | 1 | |c 2018 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. | ||
| 700 | 1 | |a Wang, Qian |4 oth | |
| 700 | 1 | |a Gan, Jingwen |4 oth | |
| 700 | 1 | |a Zhang, Shilong |4 oth | |
| 700 | 1 | |a Ye, Meixia |4 oth | |
| 700 | 1 | |a Gragnoli, Claudia |4 oth | |
| 700 | 1 | |a Wu, Rongling |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Triazolopyridazine LRRK2 kinase inhibitors |d 2013 |g Amsterdam [u.a.] |w (DE-627)ELV011759550 |
| 773 | 1 | 8 | |g volume:23 |g year:2018 |g number:11 |g pages:1883-1888 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.drudis.2018.06.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 46.00 |j Tiermedizin: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 23 |j 2018 |e 11 |h 1883-1888 |g 6 | ||
| author_variant |
k w kw |
|---|---|
| matchkey_str |
weikunwangqianganjingwenzhangshilongyeme:2018----:apngnsoducrn |
| hierarchy_sort_str |
2018 |
| bklnumber |
46.00 |
| publishDate |
2018 |
| allfields |
10.1016/j.drudis.2018.06.011 doi GBV00000000000417.pica (DE-627)ELV044655673 (ELSEVIER)S1359-6446(18)30023-0 DE-627 ger DE-627 rakwb eng 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Wei, Kun verfasserin aut Mapping genes for drug chronotherapy 2018 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. Wang, Qian oth Gan, Jingwen oth Zhang, Shilong oth Ye, Meixia oth Gragnoli, Claudia oth Wu, Rongling oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:23 year:2018 number:11 pages:1883-1888 extent:6 https://doi.org/10.1016/j.drudis.2018.06.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 23 2018 11 1883-1888 6 |
| spelling |
10.1016/j.drudis.2018.06.011 doi GBV00000000000417.pica (DE-627)ELV044655673 (ELSEVIER)S1359-6446(18)30023-0 DE-627 ger DE-627 rakwb eng 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Wei, Kun verfasserin aut Mapping genes for drug chronotherapy 2018 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. Wang, Qian oth Gan, Jingwen oth Zhang, Shilong oth Ye, Meixia oth Gragnoli, Claudia oth Wu, Rongling oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:23 year:2018 number:11 pages:1883-1888 extent:6 https://doi.org/10.1016/j.drudis.2018.06.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 23 2018 11 1883-1888 6 |
| allfields_unstemmed |
10.1016/j.drudis.2018.06.011 doi GBV00000000000417.pica (DE-627)ELV044655673 (ELSEVIER)S1359-6446(18)30023-0 DE-627 ger DE-627 rakwb eng 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Wei, Kun verfasserin aut Mapping genes for drug chronotherapy 2018 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. Wang, Qian oth Gan, Jingwen oth Zhang, Shilong oth Ye, Meixia oth Gragnoli, Claudia oth Wu, Rongling oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:23 year:2018 number:11 pages:1883-1888 extent:6 https://doi.org/10.1016/j.drudis.2018.06.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 23 2018 11 1883-1888 6 |
| allfieldsGer |
10.1016/j.drudis.2018.06.011 doi GBV00000000000417.pica (DE-627)ELV044655673 (ELSEVIER)S1359-6446(18)30023-0 DE-627 ger DE-627 rakwb eng 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Wei, Kun verfasserin aut Mapping genes for drug chronotherapy 2018 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. Wang, Qian oth Gan, Jingwen oth Zhang, Shilong oth Ye, Meixia oth Gragnoli, Claudia oth Wu, Rongling oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:23 year:2018 number:11 pages:1883-1888 extent:6 https://doi.org/10.1016/j.drudis.2018.06.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 23 2018 11 1883-1888 6 |
| allfieldsSound |
10.1016/j.drudis.2018.06.011 doi GBV00000000000417.pica (DE-627)ELV044655673 (ELSEVIER)S1359-6446(18)30023-0 DE-627 ger DE-627 rakwb eng 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Wei, Kun verfasserin aut Mapping genes for drug chronotherapy 2018 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. Wang, Qian oth Gan, Jingwen oth Zhang, Shilong oth Ye, Meixia oth Gragnoli, Claudia oth Wu, Rongling oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:23 year:2018 number:11 pages:1883-1888 extent:6 https://doi.org/10.1016/j.drudis.2018.06.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 23 2018 11 1883-1888 6 |
| language |
English |
| source |
Enthalten in Triazolopyridazine LRRK2 kinase inhibitors Amsterdam [u.a.] volume:23 year:2018 number:11 pages:1883-1888 extent:6 |
| sourceStr |
Enthalten in Triazolopyridazine LRRK2 kinase inhibitors Amsterdam [u.a.] volume:23 year:2018 number:11 pages:1883-1888 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Tiermedizin: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
540 |
| isfreeaccess_bool |
false |
| container_title |
Triazolopyridazine LRRK2 kinase inhibitors |
| authorswithroles_txt_mv |
Wei, Kun @@aut@@ Wang, Qian @@oth@@ Gan, Jingwen @@oth@@ Zhang, Shilong @@oth@@ Ye, Meixia @@oth@@ Gragnoli, Claudia @@oth@@ Wu, Rongling @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011759550 |
| dewey-sort |
3540 |
| id |
ELV044655673 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044655673</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624111913.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drudis.2018.06.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000417.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044655673</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1359-6446(18)30023-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">22</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">46.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wei, Kun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Mapping genes for drug chronotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Qian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gan, Jingwen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Shilong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ye, Meixia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gragnoli, Claudia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Rongling</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Triazolopyridazine LRRK2 kinase inhibitors</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011759550</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1883-1888</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drudis.2018.06.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">46.00</subfield><subfield code="j">Tiermedizin: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2018</subfield><subfield code="e">11</subfield><subfield code="h">1883-1888</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| author |
Wei, Kun |
| spellingShingle |
Wei, Kun ddc 540 ddc 610 ddc 630 ssgn 22 bkl 46.00 Mapping genes for drug chronotherapy |
| authorStr |
Wei, Kun |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011759550 |
| format |
electronic Article |
| dewey-ones |
540 - Chemistry & allied sciences 610 - Medicine & health 630 - Agriculture & related technologies |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Mapping genes for drug chronotherapy |
| topic |
ddc 540 ddc 610 ddc 630 ssgn 22 bkl 46.00 |
| topic_unstemmed |
ddc 540 ddc 610 ddc 630 ssgn 22 bkl 46.00 |
| topic_browse |
ddc 540 ddc 610 ddc 630 ssgn 22 bkl 46.00 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
q w qw j g jg s z sz m y my c g cg r w rw |
| hierarchy_parent_title |
Triazolopyridazine LRRK2 kinase inhibitors |
| hierarchy_parent_id |
ELV011759550 |
| dewey-tens |
540 - Chemistry 610 - Medicine & health 630 - Agriculture |
| hierarchy_top_title |
Triazolopyridazine LRRK2 kinase inhibitors |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011759550 |
| title |
Mapping genes for drug chronotherapy |
| ctrlnum |
(DE-627)ELV044655673 (ELSEVIER)S1359-6446(18)30023-0 |
| title_full |
Mapping genes for drug chronotherapy |
| author_sort |
Wei, Kun |
| journal |
Triazolopyridazine LRRK2 kinase inhibitors |
| journalStr |
Triazolopyridazine LRRK2 kinase inhibitors |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science 600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
1883 |
| author_browse |
Wei, Kun |
| container_volume |
23 |
| physical |
6 |
| class |
540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Wei, Kun |
| doi_str_mv |
10.1016/j.drudis.2018.06.011 |
| dewey-full |
540 610 630 |
| title_sort |
mapping genes for drug chronotherapy |
| title_auth |
Mapping genes for drug chronotherapy |
| abstract |
• Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. |
| abstractGer |
• Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. |
| abstract_unstemmed |
• Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
11 |
| title_short |
Mapping genes for drug chronotherapy |
| url |
https://doi.org/10.1016/j.drudis.2018.06.011 |
| remote_bool |
true |
| author2 |
Wang, Qian Gan, Jingwen Zhang, Shilong Ye, Meixia Gragnoli, Claudia Wu, Rongling |
| author2Str |
Wang, Qian Gan, Jingwen Zhang, Shilong Ye, Meixia Gragnoli, Claudia Wu, Rongling |
| ppnlink |
ELV011759550 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.drudis.2018.06.011 |
| up_date |
2024-07-06T22:04:29.564Z |
| _version_ |
1803868930903638016 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044655673</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624111913.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drudis.2018.06.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000417.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044655673</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1359-6446(18)30023-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">22</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">46.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wei, Kun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Mapping genes for drug chronotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Incorporating pharmacokinetics–pharmacodynamics facilitates pharmacogenomics. • The marriage of circadian rhythms captures the right time of drug injection. • Chronotherapy aims to maximize drug efficiency and minimize drug toxicity. • A new evolutionary concept makes chronotherapy more efficacious and established.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Qian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gan, Jingwen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Shilong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ye, Meixia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gragnoli, Claudia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Rongling</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Triazolopyridazine LRRK2 kinase inhibitors</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011759550</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1883-1888</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drudis.2018.06.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">46.00</subfield><subfield code="j">Tiermedizin: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2018</subfield><subfield code="e">11</subfield><subfield code="h">1883-1888</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| score |
7.400736 |